A novel fish interferon-derived antimicrobial peptide with rapid, broad-spectrum bactericidal activity and low toxicity for aquaculture disease control
Aug 2026· Aquaculture International· Vol 34· 0 citations· 62 references
TL;DR
Findings identify RRL14 as a promising fish interferon-derived antimicrobial peptide with potent antibacterial activity, excellent stability, low toxicity, and considerable potential for the prevention and treatment of bacterial diseases in aquaculture.
The consensus-sequence approach toward novel Brevinin-2 AMP discovery via alignment combined with in vitro antimicrobial analysis shows promise to test and initially validate other peptides, and establishes a streamlined pipeline for Brevinin-2 peptide development.
Colin M. McDowell, Jessica D. Carder, J. Brozik et al.· Applied and Environmental Mi...· 0 citations
While the peptide shows promising in vitro dual antibacterial and toxin-neutralizing capacity, its high sensitivity to proteinase K limits oral application.
En Liu, Wei-Ping Huo, Fu-Li Xu et al.· Applied Biochemistry and Bio...· 0 citations
The rapid rise of multidrug-resistant pathogens, poses a serious global threat, highlighting the need for new antimicrobial solutions. In this context, antimicrobial peptides (AMPs) have emerged as strong therapeutic candidates. Among potential targets, the MurT ligase, an ATP-dependent and highly conserved enzyme in G...
Nupur Pathak, V. Kohila· Scientific Reports· 0 citations
PAM3-2 is a proteinaceous bacteriocin-like antibacterial substance produced by marine-derived A. pittii with high physicochemical stability, and exhibits broad-spectrum antibacterial activity, particularly against S. Paratyphi B, and its antibacterial effect is associated with disruption of membrane integrity.
Yi-Jun Zhen, Yi Ma, Yun-Er Long et al.· Annals of Microbiology· 0 citations
Findings demonstrate that FL18-based chimerization provides a modular and effective strategy for tuning antibacterial activity, biocompatibility, and peptide–cell interaction behavior, underscoring their promise as building blocks for the design of next-generation antimicrobial peptide platforms.
N. Zencirci, Busra Kilic, Öznur Akbal Vural et al.· ACS Omega· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.